HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanne Asenbaum Selected Research

2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)

11/2003Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.
7/2002Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
5/2002[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
1/2002Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanne Asenbaum Research Topics

Disease

4Parkinsonian Disorders (Parkinsonism)
07/2016 - 01/2002
4Parkinson Disease (Parkinson's Disease)
01/2012 - 01/2002
2Obesity
08/2014 - 01/2013
2Temporal Lobe Epilepsy
11/2010 - 04/2003
1Corticobasal Degeneration
02/2013
1Overweight
01/2013
1Dementia (Dementias)
01/2013
1Hyperphagia (Overeating)
01/2013
1Multiple System Atrophy
01/2012
1Glioma (Gliomas)
03/2010
1Treatment-Resistant Schizophrenia
03/2010
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
12/2009
1Major Depressive Disorder (Major Depressive Disorders)
05/2009
1Glioblastoma (Glioblastoma Multiforme)
09/2007
1Bipolar Disorder (Manic Depressive Psychosis)
01/2007
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
08/2005
1Psychotic Disorders (Schizoaffective Disorder)
04/2003
1Schizophrenia (Dementia Praecox)
07/2002
1Bulimia (Binge Eating)
07/2002
1Tourette Syndrome (Tourette's Syndrome)
07/2002
1Mental Disorders (Mental Disorder)
07/2002
1Disease Progression
01/2002
1Essential Tremor (Essential Tremors)
01/2002

Drug/Important Bio-Agent (IBA)

4Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2013 - 07/2002
42beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA
11/2003 - 01/2002
3Serotonin (5 Hydroxytryptamine)IBA
08/2014 - 07/2002
22- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
07/2016 - 01/2013
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
08/2014 - 12/2009
2Dopamine (Intropin)FDA LinkGeneric
01/2013 - 01/2002
25-HT1A Serotonin ReceptorIBA
11/2010 - 07/2002
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2009 - 07/2002
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
02/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1Cetirizine (Zyrtec)FDA LinkGeneric
01/2012
1N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
11/2010
1AcidsIBA
03/2010
1PorphyrinsIBA
03/2010
1Clozapine (Clozaril)FDA LinkGeneric
03/2010
1EscitalopramFDA Link
05/2009
1CitalopramFDA LinkGeneric
05/2009
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2007
1Methionine (L-Methionine)FDA Link
09/2007
1Olanzapine (Zyprexa)FDA Link
01/2007
1Phenobarbital (Luminal)FDA Link
08/2005
1OximesIBA
04/2003
1Psychotropic Drugs (Psychoactive Drugs)IBA
07/2002
1Pharmaceutical PreparationsIBA
07/2002
1LigandsIBA
07/2002
1Biological ProductsIBA
07/2002